Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rhea Sancassani"'
Autor:
Fouad G. Souki, MD, MS, Yehuda Raveh, MD, Rhea Sancassani, MD, FACC, Joshua Livingstone, MD, Vadim Shatz, MD, Behrouz Ashrafi, MD, Miryam Shuman, MD, Ramona Nicolau-Raducu, MD, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 7, p e1499 (2023)
Background. New-onset systolic heart failure (HF) after liver transplantation (LT) is a significant cause of morbidity and mortality; however, its characteristics are still insufficiently delineated. HF may involve the left ventricle (LV), right vent
Externí odkaz:
https://doaj.org/article/a44cdbfa3f1942f2947766109d0e109b
Publikováno v:
JACC: Case Reports, Vol 2, Iss 9, Pp 1252-1255 (2020)
A 49-year-old man presented with worsening high-grade fevers, dry cough, and shortness of breath. He tested positive for severe acute respiratory syndrome-coronavirus-2 and was noted to have bradycardia with intermittent high-degree atrioventricular
Externí odkaz:
https://doaj.org/article/4e9877cace3844128f314be501764518
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 13 (2019)
Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients. It can be classified as direct (dose-dependent vs dose-independent) or indirect
Externí odkaz:
https://doaj.org/article/3a9974efee5246b0b8528db6e3175bac
Publikováno v:
CASE. 6:3-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9188312a4408f44cb6e3c6a6f7bb6c8
https://doi.org/10.1016/j.case.2021.09.012
https://doi.org/10.1016/j.case.2021.09.012
Autor:
Michael Dangl, Jelani K. Grant, Louis Vincent, Bertrand Ebner, Jennifer Maning, Odunayo Olorunfemi, Gerardo Zablah, Rhea Sancassani, Rosario Colombo
Publikováno v:
Journal of cardiac surgeryREFERENCES. 37(12)
In this study, we sought to evaluate the prevalence and association of pre-transplant atrial fibrillation (AF) on 30-day postoperative outcomes in patients undergoing orthotopic liver transplant (OLT).The National Inpatient Sample Database was querie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::380b4a2951ee9ba4073f3863b394ddfb
https://pubmed.ncbi.nlm.nih.gov/36403274
https://pubmed.ncbi.nlm.nih.gov/36403274
Publikováno v:
The American Journal of Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6f85e25f43e4838ca38969d5e1e874
https://doi.org/10.1016/j.amjmed.2020.11.025
https://doi.org/10.1016/j.amjmed.2020.11.025
Autor:
Rhea Sancassani, Jelani Grant, Jennifer Maning, Neal Olarte, Louis Vincent, Rosario Colombo, Odunayo P Olorunfemi, Bertrand Ebner, Michael Dangl
Publikováno v:
Circulation. 143
Introduction: Pre-orthotropic liver transplant (OLT) cardiac risk assessment commonly focuses on evaluation of coronary artery disease (CAD). However, the effect of atrial fibrillation (AF) on post-OLT outcomes is less well known. In this study, we s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9947d0e7958c112adb40eee971f78bd
https://doi.org/10.1161/circ.143.suppl_1.p025
https://doi.org/10.1161/circ.143.suppl_1.p025
Autor:
Michael, Dangl, Trevor, Eisenberg, Jelani K, Grant, Louis, Vincent, Rosario, Colombo, Rhea, Sancassani, Joao, Braghiroli, Paul, Martin, Rodrigo, Vianna, Ramona, Nicolau-Raducu, Cesar, Mendoza
Publikováno v:
Transplantation Reviews. 36:100709
The prevalence of coronary artery disease has increased in patients with end stage liver disease. In the near future, non-alcoholic steatohepatitis is expected to be the leading cause of end stage liver disease and shares common risk factors with cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329247a9f95ef54c5093c9cd43c03f47
https://doi.org/10.1016/j.trre.2022.100709
https://doi.org/10.1016/j.trre.2022.100709
Autor:
Jelani Grant, Rhea Sancassani, Mark Jacobs, Neal Olarte, Rosario Colombo, Colin Mackenzie, Gilson Costa-Fernandes, Rhea Patil
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 13
Background: Current guidelines recommend wearable cardioverter-defibrillator (WCD) for primary prevention of sudden cardiac death (SCD) in patients with ischemic cardiomyopathy and ejection fraction (EF) less than 35% if they are within 40 days of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f80974632fde77053434b3c881098145
https://doi.org/10.1161/hcq.13.suppl_1.364
https://doi.org/10.1161/hcq.13.suppl_1.364
Autor:
Jennifer Maning, Ivan Mendoza, Colombo Rosario, Louis Vincent, Jelani Grant, Michael Dangl, Neal Olarte, Odunayo Olorunfemi, Bertrand Ebner, Rhea Sancassani
Publikováno v:
Heart Rhythm. 18:S417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e536d384affd612af476d6e5d47ff7ab
https://doi.org/10.1016/j.hrthm.2021.06.1030
https://doi.org/10.1016/j.hrthm.2021.06.1030